Hepatocellular Carcinoma in the Pediatric Population: A Population Based Clinical Outcomes Study Involving 257 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973–2011)

Table 7

Comparing survival outcomes of fibrolamellar and nonfibrolamellar hepatocellular carcinoma from the Surveillance, Epidemiology, and End Results (SEER) database, 1973–2011.

	fHCC	Non-fHCC	value
(%)	274 (0.4%)	63,497 (99.6%)	—
Survival by treatment, (years ± SD)
No treatment	1.916 ± 0.464	1.246 ± 0.046	<0.001
Surgery only	11.325 ± 0.966	8.345 ± 0.296	<0.001
Radiation only	1.111 ± 0.348	1.190 ± 0.064	<0.001
Both surgery and radiation	7.393 ± 2.937	3.475 ± 0.489	<0.001
Cumulative survival (%)
1-year	67%	34%	<0.001
2-year	50%	23%	<0.001
5-year	31%	12%	<0.001

fHCC = fibrolamellar hepatocellular carcinoma; = number; SD = standard deviation; data presented for patients with available information only.